Philips NV

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 11:38:29 2024-04-29 am EDT			Pre-market 02:57:36 am
25.54 ^EUR	+29.35%		25.46	-0.33%

07:14am	PHILIPS NV : UBS from Sell to Neutral	ZD
07:12am	PHILIPS NV : JP Morgan from Sell to Neutral	ZD

PHILIPS NV : Goldman Sachs maintains a Buy rating

October 20, 2020 at 05:29 am EDT

Goldman Sachs analyst Veronika Dubajova maintains his Buy rating on the stock. Previously set at EUR 47.50, the target price has been raised to EUR 50.

Latest news about Philips NV

PHILIPS NV : UBS from Sell to Neutral	01:14am	ZD
PHILIPS NV : JP Morgan from Sell to Neutral	01:12am	ZD
ROYAL PHILIPS : The Dutch giant now poised for much better times	Apr. 29
PHILIPS NV : Barclays remains its Buy rating	Apr. 29	ZD
ROYAL PHILIPS : Litigation uncertainty no longer an overhang; Q1 profitability beat	Apr. 29
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	Apr. 29	MT
Top Premarket Gainers	Apr. 29	MT
PHILIPS NV : UBS reiterates its Sell rating	Apr. 29	ZD
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook	Apr. 29	MT
European shares hit two-week high; inflation data, Fed meeting in focus	Apr. 29	RE
PHILIPS NV : Receives a Buy rating from Goldman Sachs	Apr. 29	ZD
Transcript : Koninklijke Philips N.V., Q1 2024 Earnings Call, Apr 29, 2024	Apr. 29
PHILIPS NV : JP Morgan reaffirms its Sell rating	Apr. 29	ZD
Philips: quarterly loss on heavy provision	Apr. 29	CF
Koninklijke Philips N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Royal Philips Affirms FY24 Sales Outlook	Apr. 29	MT
Philips: agreement on Respironics litigation	Apr. 29	CF
Philips Secures $1.1 Billion Settlement Deal for US Class Action Over Recalled Sleep Devices	Apr. 29	MT
Philips pays $1.1 bln in U.S. settlement over ventilator recall	Apr. 29	RE
EMEA Morning Briefing: Stocks May Rise; Fed, Earnings in Focus This Week	Apr. 29	DJ
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	Apr. 25	RE
PHILIPS NV : Jefferies reiterates its Sell rating	Apr. 23	ZD
PHILIPS NV : Receives a Sell rating from Jefferies	Apr. 18	ZD
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
HSBC Upgrades Koninklijke Philips to Hold From Reduce	Apr. 12	MT

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-29 - Roadshow - BNP Paribas

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ROYAL PHILIPS : The Dutch giant now poised for much better times

April 29, 2024 at 01:48 pm EDT

Philips NV : The sleep apnea case makes a brutal comeback

October 06, 2023 at 05:20 am EDT

Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO

September 29, 2023 at 10:33 am EDT

More Strategies

Ratings for Philips NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

25.54 EUR

Average target price

20.65 EUR

Spread / Average Target

-19.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PHILIPS NV	+21.13%	24.75B
THERMO FISHER SCIENTIFIC	+8.69%	220B
DANAHER CORPORATION	+6.69%	183B
INTUITIVE SURGICAL, INC.	+10.90%	133B
BOSTON SCIENTIFIC CORPORATION	+25.41%	107B
SIEMENS HEALTHINEERS AG	+0.27%	63.05B
EDWARDS LIFESCIENCES CORPORATION	+12.72%	51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.47B
AGILENT TECHNOLOGIES, INC.	+0.40%	40.91B
GE HEALTHCARE TECHNOLOGIES INC.	+15.03%	40.59B

Other Advanced Medical Equipment & Technology

Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

PHILIPS NV : Goldman Sachs maintains a Buy rating

Latest news about Philips NV

Chart Philips NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Philips NV

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology